person · Reporting owner

KANIA DON R

Disclosed activity across 4 companies

Tapewire entity: 15217
SEC CIK: 0001254028

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

No relationships currently tracked through insider filings.

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

No balances currently tracked through insider filings.

Past disclosures · reporting ended (4)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

AMERICAN SCIENCE & ENGINEERING, INC.

Report date September 09, 2016 · Filed September 12, 2016

Section 16 reporting ended · disclosed 2016-09-12. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosure context
Common StockSEC Table I · non-derivative	Direct	Reported balance After 2016-09-09 transaction · row 1 1 source row Row 1 · 2016-09-09 · Disposition to issuer · Disposed 10,847 · Balance 0 F1: On September 9, 2016, pursuant to the Agreement and Plan of Merger among the issuer, OSI Systems, Inc. ("Buyer") and Apple Merger Sub, Inc., a wholly owned subsidiary of Buyer ("Merger Sub"), dated June 20, 2016 (the "Merger Agreement"), Merger Sub merged with and into the issuer (the "Merger"), with the issuer surviving the Merger as a wholly owned subsidiary of Buyer. Pursuant to the Merger Agreement, at the effective time of the Merger, the shares automatically converted into the right to receive $37.00 per share in cash.
Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $75.82 · Expires 2020-05-02	Direct	Reported balance After 2016-09-09 transaction · row 2 Instrument identity requires review; Table II rows are not merged. 1 source row Row 2 · 2016-09-09 · Disposition to issuer · Disposed 4,181 · Balance 0 F2: This option was cancelled for no consideration pursuant to the terms of the Merger Agreement.
Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $74.79 · Expires 2020-09-08	Direct	Reported balance After 2016-09-09 transaction · row 3 Instrument identity requires review; Table II rows are not merged. 1 source row Row 3 · 2016-09-09 · Disposition to issuer · Disposed 7,000 · Balance 0 F2: This option was cancelled for no consideration pursuant to the terms of the Merger Agreement.

Filing footnotes · ownership attribution and instrument terms

F1: On September 9, 2016, pursuant to the Agreement and Plan of Merger among the issuer, OSI Systems, Inc. ("Buyer") and Apple Merger Sub, Inc., a wholly owned subsidiary of Buyer ("Merger Sub"), dated June 20, 2016 (the "Merger Agreement"), Merger Sub merged with and into the issuer (the "Merger"), with the issuer surviving the Merger as a wholly owned subsidiary of Buyer. Pursuant to the Merger Agreement, at the effective time of the Merger, the shares automatically converted into the right to receive $37.00 per share in cash.

F2: This option was cancelled for no consideration pursuant to the terms of the Merger Agreement.

FEI CO

Report date September 19, 2016 · Filed September 21, 2016

Section 16 reporting ended · disclosed 2016-09-21. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosure context
Common StockSEC Table I · non-derivative	Direct	Reported balance After 2016-09-19 transaction · row 1 1 source row Row 1 · 2016-09-19 · Other · Disposed 48,486 · Balance 0 F1: Disposed of at the effective time of the merger of Polpis Merger Sub Co. ("Merger Sub"), a wholly owned subsidiary of Thermo Fisher Scientific Inc. ("Thermo Fisher"), with and into the Issuer (the "Merger"), pursuant to that certain Agreement and Plan of Merger dated May 26, 2016, between the Issuer, Thermo Fisher and Merger Sub (the "Merger Agreement"), in exchange for a cash payment of $107.50 per share.
Stock OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $23.98 · Expires 2017-11-04	Direct	Reported balance After 2016-09-19 transaction · row 2 Instrument identity requires review; Table II rows are not merged. 1 source row Row 2 · 2016-09-19 · Disposition to issuer · Disposed 26,000 · Balance 0 F2: The option, which became fully vested on November 4, 2014, originally covered 72,000 shares but was exercised as to 46,000 shares prior to the Merger. At or immediately prior to the effective time of the Merger, the unexercised portion of the option was cancelled in exchange for a cash payment equal to (x) the difference between $107.50 and the per share exercise price of the option, multiplied by (y) the number of shares subject to such portion of the option.
Stock OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $39.76 · Expires 2018-10-31	Direct	Reported balance After 2016-09-19 transaction · row 3 Instrument identity requires review; Table II rows are not merged. 1 source row Row 3 · 2016-09-19 · Disposition to issuer · Disposed 37,412 · Balance 0 F3: The option, which became fully vested on October 31, 2015, originally covered 74,824 shares but was exercised as to 37,412 shares prior to the Merger. At or immediately prior to the effective time of the Merger, the unexercised portion of the option was cancelled in exchange for a cash payment equal to (x) the difference between $107.50 and the per share exercise price of the option, multiplied by (y) the number of shares subject to such portion of the option.
Stock OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $55.16 · Expires 2019-11-01	Direct	Reported balance After 2016-09-19 transaction · row 4 Instrument identity requires review; Table II rows are not merged. 1 source row Row 4 · 2016-09-19 · Disposition to issuer · Disposed 60,776 · Balance 0 F4: The option was scheduled to vest in four equal annual installments beginning on November 1, 2013. At or immediately prior to the effective time of the Merger, the unexercised portion of the option was assumed by Thermo Fisher and converted into an award representing a right to receive a cash amount equal to (x) the difference between $107.50 and the per share exercise price of the option, multiplied by (y) the number of shares subject to such portion of the option, subject to the vesting terms of the Issuer's 1995 Stock Incentive Plan and the award agreement evidencing such option, in each case as in effect immediately prior to the effective time of the Merger.
Stock OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $89.08 · Expires 2020-10-31	Direct	Reported balance After 2016-09-19 transaction · row 5 Instrument identity requires review; Table II rows are not merged. 1 source row Row 5 · 2016-09-19 · Disposition to issuer · Disposed 41,356 · Balance 0 F5: The option was scheduled to vest in four equal annual installments beginning on October 31, 2014. At or immediately prior to the effective time of the Merger, the unexercised portion of the option was assumed by Thermo Fisher and converted into an award representing a right to receive a cash amount equal to (x) the difference between $107.50 and the per share exercise price of the option, multiplied by (y) the number of shares subject to such portion of the option, subject to the vesting terms of the Issuer's 1995 Stock Incentive Plan and the award agreement evidencing such option, in each case as in effect immediately prior to the effective time of the Merger.
Stock OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $81.88 · Expires 2021-05-19	Direct	Reported balance After 2016-09-19 transaction · row 6 Instrument identity requires review; Table II rows are not merged. 1 source row Row 6 · 2016-09-19 · Disposition to issuer · Disposed 64,612 · Balance 0 F6: The option was scheduled to vest in four equal annual installments beginning on May 19, 2015. At or immediately prior to the effective time of the Merger, the unexercised portion of the option was assumed by Thermo Fisher and converted into an award representing a right to receive a cash amount equal to (x) the difference between $107.50 and the per share exercise price of the option, multiplied by (y) the number of shares subject to such portion of the option, subject to the vesting terms of the Issuer's 1995 Stock Incentive Plan and the award agreement evidencing such option, in each case as in effect immediately prior to the effective time of the Merger.
Stock OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $81.15 · Expires 2022-05-22	Direct	Reported balance After 2016-09-19 transaction · row 7 Instrument identity requires review; Table II rows are not merged. 1 source row Row 7 · 2016-09-19 · Disposition to issuer · Disposed 82,697 · Balance 0 F7: The option was scheduled to vest in four equal annual installments beginning on May 22, 2016. At or immediately prior to the effective time of the Merger, the unexercised portion of the option was assumed by Thermo Fisher and converted into an award representing a right to receive a cash amount equal to (x) the difference between $107.50 and the per share exercise price of the option, multiplied by (y) the number of shares subject to such portion of the option, subject to the vesting terms of the Issuer's 1995 Stock Incentive Plan and the award agreement evidencing such option, in each case as in effect immediately prior to the effective time of the Merger.
RSUsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00	Direct	Reported balance After 2016-09-19 transaction · row 8 Instrument identity requires review; Table II rows are not merged. 1 source row Row 8 · 2016-09-19 · Disposition to issuer · Disposed 5,844 · Balance 0 F8: Each of the restricted share units ("RSUs") represents the right to receive, following vesting, one share of the Issuer's common stock. These RSUs do not expire, unless forfeited under the terms of the RSUs. F9: The RSUs were scheduled to vest in four equal annual installments beginning on November 1, 2013. At or immediately prior to the effective time of the Merger, the outstanding RSUs were assumed by Thermo Fisher and converted into an award representing a right to receive a cash amount equal to (x) $107.50 multiplied by (y) the total number of outstanding shares of the Issuer's common stock that would have been delivered to Mr. Kania on each future vesting date of such RSUs (or on each future delivery date of such RSUs, if such delivery date is later than the related vesting date), subject to the vesting and delivery terms of the Issuer's 1995 Stock Incentive Plan and the award agreement evidencing such RSUs, in each case as in effect immediately prior to the effective time of the Merger.
RSUsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00	Direct	Reported balance After 2016-09-19 transaction · row 9 Instrument identity requires review; Table II rows are not merged. 1 source row Row 9 · 2016-09-19 · Disposition to issuer · Disposed 7,952 · Balance 0 F8: Each of the restricted share units ("RSUs") represents the right to receive, following vesting, one share of the Issuer's common stock. These RSUs do not expire, unless forfeited under the terms of the RSUs. F10: The RSUs were scheduled to vest in four equal annual installments beginning on October 31, 2014. At or immediately prior to the effective time of the Merger, the outstanding RSUs were assumed by Thermo Fisher and converted into an award representing a right to receive a cash amount equal to (x) $107.50 multiplied by (y) the total number of outstanding shares of the Issuer's common stock that would have been delivered to Mr. Kania on each future vesting date of such RSUs (or on each future delivery date of such RSUs, if such delivery date is later than the related vesting date), subject to the vesting and delivery terms of the Issuer's 1995 Stock Incentive Plan and the award agreement evidencing such RSUs, in each case as in effect immediately prior to the effective time of the Merger.
RSUsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00	Direct	Reported balance After 2016-09-19 transaction · row 10 Instrument identity requires review; Table II rows are not merged. 1 source row Row 10 · 2016-09-19 · Disposition to issuer · Disposed 7,692 · Balance 0 F8: Each of the restricted share units ("RSUs") represents the right to receive, following vesting, one share of the Issuer's common stock. These RSUs do not expire, unless forfeited under the terms of the RSUs. F11: The RSUs were scheduled to vest in four equal annual installments beginning on May 9, 2015. At or immediately prior to the effective time of the Merger, the outstanding RSUs were assumed by Thermo Fisher and converted into an award representing a right to receive a cash amount equal to (x) $107.50 multiplied by (y) the total number of outstanding shares of the Issuer's common stock that would have been delivered to Mr. Kania on each future vesting date of such RSUs (or on each future delivery date of such RSUs, if such delivery date is later than the related vesting date), subject to the vesting and delivery terms of the Issuer's 1995 Stock Incentive Plan and the award agreement evidencing such RSUs, in each case as in effect immediately prior to the effective time of the Merger.
RSUsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00	Direct	Reported balance After 2016-09-19 transaction · row 11 Instrument identity requires review; Table II rows are not merged. 1 source row Row 11 · 2016-09-19 · Disposition to issuer · Disposed 12,405 · Balance 0 F8: Each of the restricted share units ("RSUs") represents the right to receive, following vesting, one share of the Issuer's common stock. These RSUs do not expire, unless forfeited under the terms of the RSUs. F12: The RSUs were scheduled to vest in four equal annual installments beginning on May 23, 2016. At or immediately prior to the effective time of the Merger, the outstanding RSUs were assumed by Thermo Fisher and converted into an award representing a right to receive a cash amount equal to (x) $107.50 multiplied by (y) the total number of outstanding shares of the Issuer's common stock that would have been delivered to Mr. Kania on each future vesting date of such RSUs (or on each future delivery date of such RSUs, if such delivery date is later than the related vesting date), subject to the vesting and delivery terms of the Issuer's 1995 Stock Incentive Plan and the award agreement evidencing such RSUs, in each case as in effect immediately prior to the effective time of the Merger.
RSUsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00	Direct	Reported balance After 2016-09-19 transaction · row 13 Instrument identity requires review; Table II rows are not merged. 1 source row Row 13 · 2016-09-19 · Disposition to issuer · Disposed 34,284 · Balance 0 F8: Each of the restricted share units ("RSUs") represents the right to receive, following vesting, one share of the Issuer's common stock. These RSUs do not expire, unless forfeited under the terms of the RSUs. F15: The RSUs were scheduled to vest in four equal annual installments beginning on May 17, 2017. At or immediately prior to the effective time of the Merger, the outstanding RSUs were assumed by Thermo Fisher and converted into an award representing a right to receive a cash amount equal to (x) $107.50 multiplied by (y) the total number of outstanding shares of the Issuer's common stock that would have been delivered to Mr. Kania on each future vesting date of such RSUs (or on each future delivery date of such RSUs, if such delivery date is later than the related vesting date), subject to the vesting and delivery terms of the Issuer's 1995 Stock Incentive Plan and the award agreement evidencing such RSUs, in each case as in effect immediately prior to the effective time of the Merger.
Performance-based RSUsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00	Direct	Reported balance After 2016-09-19 transaction · row 12 Instrument identity requires review; Table II rows are not merged. 1 source row Row 12 · 2016-09-19 · Disposition to issuer · Disposed 19,109 · Balance 0 F13: These RSUs are performance-based RSUs, for which the number of RSUs that would vest was to be determined by the Issuer achieving targeted average annual revenue growth during the period from January 1, 2016 through December 31, 2018. In addition, vesting was subject to minimum thresholds for average operating income and average annual revenue growth. A portion of the RSUs were scheduled to vest if the Issuer achieved the thresholds and vesting would increase with performance up to a cap of 19,109 RSUs, which represented 200% of the RSUs that vest upon achievement of the performance metrics at target levels. Performance would be assessed and vesting determined after the Issuer finalized financial results for 2018, which was expected to be on or about February 6, 2019. RSUs that did not vest in accordance with the foregoing would be forfeited. F14: At or immediately prior to the effective time of the Merger, these performance-based RSUs were assumed by Thermo Fisher and converted into an award representing a right to receive a cash amount equal to (x) $107.50 multiplied by (y) the total number of outstanding shares of the Issuer's common stock that would have been delivered to Mr. Kania on each future vesting date of such RSUs (or on each future delivery date of such RSUs, if such delivery date is later than the related vesting date), subject to the vesting and delivery terms of the Issuer's 1995 Stock Incentive Plan and the award agreement evidencing such RSUs, in each case as in effect immediately prior to the effective time of the Merger, except that the performance metrics were deemed to have been achieved at target as of the effective time of the Merger. F8: Each of the restricted share units ("RSUs") represents the right to receive, following vesting, one share of the Issuer's common stock. These RSUs do not expire, unless forfeited under the terms of the RSUs.

Filing footnotes · ownership attribution and instrument terms

F1: Disposed of at the effective time of the merger of Polpis Merger Sub Co. ("Merger Sub"), a wholly owned subsidiary of Thermo Fisher Scientific Inc. ("Thermo Fisher"), with and into the Issuer (the "Merger"), pursuant to that certain Agreement and Plan of Merger dated May 26, 2016, between the Issuer, Thermo Fisher and Merger Sub (the "Merger Agreement"), in exchange for a cash payment of $107.50 per share.

F2: The option, which became fully vested on November 4, 2014, originally covered 72,000 shares but was exercised as to 46,000 shares prior to the Merger. At or immediately prior to the effective time of the Merger, the unexercised portion of the option was cancelled in exchange for a cash payment equal to (x) the difference between $107.50 and the per share exercise price of the option, multiplied by (y) the number of shares subject to such portion of the option.

F3: The option, which became fully vested on October 31, 2015, originally covered 74,824 shares but was exercised as to 37,412 shares prior to the Merger. At or immediately prior to the effective time of the Merger, the unexercised portion of the option was cancelled in exchange for a cash payment equal to (x) the difference between $107.50 and the per share exercise price of the option, multiplied by (y) the number of shares subject to such portion of the option.

F4: The option was scheduled to vest in four equal annual installments beginning on November 1, 2013. At or immediately prior to the effective time of the Merger, the unexercised portion of the option was assumed by Thermo Fisher and converted into an award representing a right to receive a cash amount equal to (x) the difference between $107.50 and the per share exercise price of the option, multiplied by (y) the number of shares subject to such portion of the option, subject to the vesting terms of the Issuer's 1995 Stock Incentive Plan and the award agreement evidencing such option, in each case as in effect immediately prior to the effective time of the Merger.

F5: The option was scheduled to vest in four equal annual installments beginning on October 31, 2014. At or immediately prior to the effective time of the Merger, the unexercised portion of the option was assumed by Thermo Fisher and converted into an award representing a right to receive a cash amount equal to (x) the difference between $107.50 and the per share exercise price of the option, multiplied by (y) the number of shares subject to such portion of the option, subject to the vesting terms of the Issuer's 1995 Stock Incentive Plan and the award agreement evidencing such option, in each case as in effect immediately prior to the effective time of the Merger.

F6: The option was scheduled to vest in four equal annual installments beginning on May 19, 2015. At or immediately prior to the effective time of the Merger, the unexercised portion of the option was assumed by Thermo Fisher and converted into an award representing a right to receive a cash amount equal to (x) the difference between $107.50 and the per share exercise price of the option, multiplied by (y) the number of shares subject to such portion of the option, subject to the vesting terms of the Issuer's 1995 Stock Incentive Plan and the award agreement evidencing such option, in each case as in effect immediately prior to the effective time of the Merger.

F7: The option was scheduled to vest in four equal annual installments beginning on May 22, 2016. At or immediately prior to the effective time of the Merger, the unexercised portion of the option was assumed by Thermo Fisher and converted into an award representing a right to receive a cash amount equal to (x) the difference between $107.50 and the per share exercise price of the option, multiplied by (y) the number of shares subject to such portion of the option, subject to the vesting terms of the Issuer's 1995 Stock Incentive Plan and the award agreement evidencing such option, in each case as in effect immediately prior to the effective time of the Merger.

F8: Each of the restricted share units ("RSUs") represents the right to receive, following vesting, one share of the Issuer's common stock. These RSUs do not expire, unless forfeited under the terms of the RSUs.

F9: The RSUs were scheduled to vest in four equal annual installments beginning on November 1, 2013. At or immediately prior to the effective time of the Merger, the outstanding RSUs were assumed by Thermo Fisher and converted into an award representing a right to receive a cash amount equal to (x) $107.50 multiplied by (y) the total number of outstanding shares of the Issuer's common stock that would have been delivered to Mr. Kania on each future vesting date of such RSUs (or on each future delivery date of such RSUs, if such delivery date is later than the related vesting date), subject to the vesting and delivery terms of the Issuer's 1995 Stock Incentive Plan and the award agreement evidencing such RSUs, in each case as in effect immediately prior to the effective time of the Merger.

F10: The RSUs were scheduled to vest in four equal annual installments beginning on October 31, 2014. At or immediately prior to the effective time of the Merger, the outstanding RSUs were assumed by Thermo Fisher and converted into an award representing a right to receive a cash amount equal to (x) $107.50 multiplied by (y) the total number of outstanding shares of the Issuer's common stock that would have been delivered to Mr. Kania on each future vesting date of such RSUs (or on each future delivery date of such RSUs, if such delivery date is later than the related vesting date), subject to the vesting and delivery terms of the Issuer's 1995 Stock Incentive Plan and the award agreement evidencing such RSUs, in each case as in effect immediately prior to the effective time of the Merger.

F11: The RSUs were scheduled to vest in four equal annual installments beginning on May 9, 2015. At or immediately prior to the effective time of the Merger, the outstanding RSUs were assumed by Thermo Fisher and converted into an award representing a right to receive a cash amount equal to (x) $107.50 multiplied by (y) the total number of outstanding shares of the Issuer's common stock that would have been delivered to Mr. Kania on each future vesting date of such RSUs (or on each future delivery date of such RSUs, if such delivery date is later than the related vesting date), subject to the vesting and delivery terms of the Issuer's 1995 Stock Incentive Plan and the award agreement evidencing such RSUs, in each case as in effect immediately prior to the effective time of the Merger.

F12: The RSUs were scheduled to vest in four equal annual installments beginning on May 23, 2016. At or immediately prior to the effective time of the Merger, the outstanding RSUs were assumed by Thermo Fisher and converted into an award representing a right to receive a cash amount equal to (x) $107.50 multiplied by (y) the total number of outstanding shares of the Issuer's common stock that would have been delivered to Mr. Kania on each future vesting date of such RSUs (or on each future delivery date of such RSUs, if such delivery date is later than the related vesting date), subject to the vesting and delivery terms of the Issuer's 1995 Stock Incentive Plan and the award agreement evidencing such RSUs, in each case as in effect immediately prior to the effective time of the Merger.

F13: These RSUs are performance-based RSUs, for which the number of RSUs that would vest was to be determined by the Issuer achieving targeted average annual revenue growth during the period from January 1, 2016 through December 31, 2018. In addition, vesting was subject to minimum thresholds for average operating income and average annual revenue growth. A portion of the RSUs were scheduled to vest if the Issuer achieved the thresholds and vesting would increase with performance up to a cap of 19,109 RSUs, which represented 200% of the RSUs that vest upon achievement of the performance metrics at target levels. Performance would be assessed and vesting determined after the Issuer finalized financial results for 2018, which was expected to be on or about February 6, 2019. RSUs that did not vest in accordance with the foregoing would be forfeited.

F14: At or immediately prior to the effective time of the Merger, these performance-based RSUs were assumed by Thermo Fisher and converted into an award representing a right to receive a cash amount equal to (x) $107.50 multiplied by (y) the total number of outstanding shares of the Issuer's common stock that would have been delivered to Mr. Kania on each future vesting date of such RSUs (or on each future delivery date of such RSUs, if such delivery date is later than the related vesting date), subject to the vesting and delivery terms of the Issuer's 1995 Stock Incentive Plan and the award agreement evidencing such RSUs, in each case as in effect immediately prior to the effective time of the Merger, except that the performance metrics were deemed to have been achieved at target as of the effective time of the Merger.

F15: The RSUs were scheduled to vest in four equal annual installments beginning on May 17, 2017. At or immediately prior to the effective time of the Merger, the outstanding RSUs were assumed by Thermo Fisher and converted into an award representing a right to receive a cash amount equal to (x) $107.50 multiplied by (y) the total number of outstanding shares of the Issuer's common stock that would have been delivered to Mr. Kania on each future vesting date of such RSUs (or on each future delivery date of such RSUs, if such delivery date is later than the related vesting date), subject to the vesting and delivery terms of the Issuer's 1995 Stock Incentive Plan and the award agreement evidencing such RSUs, in each case as in effect immediately prior to the effective time of the Merger.

INTUITIVE SURGICAL INC

Report date April 25, 2024 · Filed April 27, 2024

Section 16 reporting ended · disclosed 2024-04-27. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	3,838	Reported balance After 2024-04-25 transaction · row 1 1 source row Row 1 · 2024-04-25 · Exercise / conversion · Acquired 569 · Balance 3,838
Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00	Direct	0	Reported balance After 2024-04-25 transaction · row 2 Instrument identity requires review; Table II rows are not merged. 1 source row Row 2 · 2024-04-25 · Exercise / conversion · Disposed 569 · Balance 0 F1: 100% of the RSUs shall vest on the earlier of the one year anniversary of the date of grant or the next Annual Meeting of Stockholders, subject to the Reporting Person's continued service.

Filing footnotes · ownership attribution and instrument terms

F1: 100% of the RSUs shall vest on the earlier of the one year anniversary of the date of grant or the next Annual Meeting of Stockholders, subject to the Reporting Person's continued service.

NanoString Technologies Inc

Report date June 16, 2022 · Filed June 17, 2022

Section 16 reporting ended · disclosed 2022-06-17. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	9,410	Reported balance After 2022-06-16 transaction · row 1 1 source row Row 1 · 2022-06-16 · Exercise / conversion · Acquired 3,890 · Balance 9,410
Restricted Stock UnitsSEC Table II · derivative / convertible security	Direct	0	Reported balance After 2022-06-16 transaction · row 2 Instrument identity requires review; Table II rows are not merged. 1 source row Row 2 · 2022-06-16 · Exercise / conversion · Disposed 3,890 · Balance 0 F1: Each restricted stock unit ("RSU") represents a contingent right to receive one (1) share of Issuer's common stock. F2: 100% of the RSUs vest on the earlier of the one year anniversary of June 16, 2021 or on the date immediately prior to the 2022 annual meeting of stockholders.

Filing footnotes · ownership attribution and instrument terms

F1: Each restricted stock unit ("RSU") represents a contingent right to receive one (1) share of Issuer's common stock.

F2: 100% of the RSUs vest on the earlier of the one year anniversary of June 16, 2021 or on the date immediately prior to the 2022 annual meeting of stockholders.

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
April 25, 2024 Filed Apr 27, 2024 00:08 UTC	INTUITIVE SURGICAL INC ISRG · Entity 2878	Exercise / conversionRestricted Stock Units · Derivative	569	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0001035267-24-000159 · edgardoc.xml · derivative · entry 2 KANIA DON R · CIK 0001254028 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 569 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: 100% of the RSUs shall vest on the earlier of the one year anniversary of the date of grant or the next Annual Meeting of Stockholders, subject to the Reporting Person's continued service. F1 · derivative.expiration_date: 100% of the RSUs shall vest on the earlier of the one year anniversary of the date of grant or the next Annual Meeting of Stockholders, subject to the Reporting Person's continued service. Read SEC document
April 25, 2024 Filed Apr 27, 2024 00:08 UTC	INTUITIVE SURGICAL INC ISRG · Entity 2878	Exercise / conversionCommon Stock	569	$0.00	$0.00	Disclosure SEC source: 0001035267-24-000159 · edgardoc.xml · nonDerivative · entry 1 KANIA DON R · CIK 0001254028 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,838 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
April 27, 2023 Filed Apr 28, 2023 21:18 UTC	INTUITIVE SURGICAL INC ISRG · Entity 2878	GrantRestricted Stock Units · Derivative	569	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0001035267-23-000112 · edgardoc.xml · derivative · entry 4 KANIA DON R · CIK 0001254028 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 569 Underlying: Common Stock · 569 shares Expires not disclosed F2 · derivative.exercise_date: 100% of the RSUs shall vest on the earlier of the one year anniversary of the date of grant or the next Annual Meeting of Stockholders, subject to the Reporting Person's continued service. F2 · derivative.expiration_date: 100% of the RSUs shall vest on the earlier of the one year anniversary of the date of grant or the next Annual Meeting of Stockholders, subject to the Reporting Person's continued service. Read SEC document
April 27, 2023 Filed Apr 28, 2023 21:18 UTC	INTUITIVE SURGICAL INC ISRG · Entity 2878	Exercise / conversionRestricted Stock Units · Derivative	482	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0001035267-23-000112 · edgardoc.xml · derivative · entry 3 KANIA DON R · CIK 0001254028 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 482 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 100% of the RSUs shall vest on the earlier of the one year anniversary of the date of grant or the next Annual Meeting of Stockholders, subject to the Reporting Person's continued service. F2 · derivative.expiration_date: 100% of the RSUs shall vest on the earlier of the one year anniversary of the date of grant or the next Annual Meeting of Stockholders, subject to the Reporting Person's continued service. Read SEC document
April 27, 2023 Filed Apr 28, 2023 21:18 UTC	INTUITIVE SURGICAL INC ISRG · Entity 2878	GrantNon-Qualified Stock Option (right to buy) · Derivative	1,709	$0.00 Strike: $295.92	$0.00	Disclosure SEC source: 0001035267-23-000112 · edgardoc.xml · derivative · entry 2 KANIA DON R · CIK 0001254028 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,709 Underlying: Common Stock · 1,709 shares Expires 2030-04-26 F1 · derivative.exercise_date: 100% of the shares subject to the option shall vest on the earlier of the one year anniversary of the date of grant or the next Annual Meeting of Stockholders, subject to the Reporting Person's continued service as a director to the issuer. Read SEC document
April 27, 2023 Filed Apr 28, 2023 21:18 UTC	INTUITIVE SURGICAL INC ISRG · Entity 2878	Exercise / conversionCommon Stock	482	$0.00	$0.00	Disclosure SEC source: 0001035267-23-000112 · edgardoc.xml · nonDerivative · entry 1 KANIA DON R · CIK 0001254028 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,269 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
June 16, 2022 Filed Jun 17, 2022 17:08 UTC	NanoString Technologies Inc NSTG · Entity 15988	Exercise / conversionRestricted Stock Units · Derivative	3,890	$0.00	$0.00	Disclosure SEC source: 0001401708-22-000122 · wf-form4_165550008723802.xml · derivative · entry 2 KANIA DON R · CIK 0001254028 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,890 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one (1) share of Issuer's common stock. F2 · derivative.exercise_date: 100% of the RSUs vest on the earlier of the one year anniversary of June 16, 2021 or on the date immediately prior to the 2022 annual meeting of stockholders. F2 · derivative.expiration_date: 100% of the RSUs vest on the earlier of the one year anniversary of June 16, 2021 or on the date immediately prior to the 2022 annual meeting of stockholders. Read SEC document
June 16, 2022 Filed Jun 17, 2022 17:08 UTC	NanoString Technologies Inc NSTG · Entity 15988	Exercise / conversionCommon Stock	3,890	$0.00	$0.00	Disclosure SEC source: 0001401708-22-000122 · wf-form4_165550008723802.xml · nonDerivative · entry 1 KANIA DON R · CIK 0001254028 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,410 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
April 28, 2022 Filed Apr 29, 2022 22:13 UTC	INTUITIVE SURGICAL INC ISRG · Entity 2878	GrantRestricted Stock Units · Derivative	482	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0001035267-22-000094 · edgardoc.xml · derivative · entry 2 KANIA DON R · CIK 0001254028 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 482 Underlying: Common Stock · 482 shares Expires not disclosed F2 · derivative.exercise_date: 100% of the RSUs shall vest on the earlier of the one year anniversary of the date of grant or the next Annual Meeting of Stockholders, subject to the Reporting Person's continued service. F2 · derivative.expiration_date: 100% of the RSUs shall vest on the earlier of the one year anniversary of the date of grant or the next Annual Meeting of Stockholders, subject to the Reporting Person's continued service. Read SEC document
April 28, 2022 Filed Apr 29, 2022 22:13 UTC	INTUITIVE SURGICAL INC ISRG · Entity 2878	GrantNon-Qualified Stock Option (right to buy) · Derivative	1,448	$0.00 Strike: $243.26	$0.00	Disclosure SEC source: 0001035267-22-000094 · edgardoc.xml · derivative · entry 1 KANIA DON R · CIK 0001254028 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,448 Underlying: Common Stock · 1,448 shares Expires 2029-04-27 F1 · derivative.exercise_date: 100% of the shares subject to the option shall vest on the earlier of the one year anniversary of the date of grant or the next Annual Meeting of Stockholders, subject to the Reporting Person's continued service as a director to the issuer. Read SEC document
April 22, 2022 Filed Apr 26, 2022 16:39 UTC	INTUITIVE SURGICAL INC ISRG · Entity 2878	Exercise / conversionRestricted Stock Units · Derivative	555	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0001567619-22-008946 · doc1.xml · derivative · entry 2 KANIA DON R · CIK 0001254028 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 555 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 100% of the RSUs shall vest on the earlier of the one year anniversary of the date of grant or the next Annual Meeting of the Stockholders, subject to the Reporting Person's continued service. F2 · derivative.expiration_date: 100% of the RSUs shall vest on the earlier of the one year anniversary of the date of grant or the next Annual Meeting of the Stockholders, subject to the Reporting Person's continued service. F1 · balance_after: On October 5, 2021, the common stock equity grants of Intuitive Surgical split 3-for-1, resulting in the Reporting Person's ownership of the company's stock and equity grants to increase (for every one share owned or granted, 2 additional shares were issued) and the exercise price of stock grants to decrease to 1/3rd of the original grant price. Read SEC document
April 22, 2022 Filed Apr 26, 2022 16:39 UTC	INTUITIVE SURGICAL INC ISRG · Entity 2878	Exercise / conversionCommon Stock	555	$0.00	$0.00	Disclosure SEC source: 0001567619-22-008946 · doc1.xml · nonDerivative · entry 1 KANIA DON R · CIK 0001254028 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,787 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: On October 5, 2021, the common stock equity grants of Intuitive Surgical split 3-for-1, resulting in the Reporting Person's ownership of the company's stock and equity grants to increase (for every one share owned or granted, 2 additional shares were issued) and the exercise price of stock grants to decrease to 1/3rd of the original grant price. Read SEC document
June 16, 2021 Filed Jun 17, 2021 19:01 UTC	NanoString Technologies Inc NSTG · Entity 15988	GrantCommon Stock · Derivative	3,890	$0.00	$0.00	Disclosure SEC source: 0001401708-21-000176 · wf-form4_162397086069886.xml · derivative · entry 3 KANIA DON R · CIK 0001254028 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,890 Underlying: Common Stock · 3,890 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one (1) share of Issuer's common stock. F3 · derivative.exercise_date: 100% of the RSUs vest on the earlier of the one year anniversary of June 16, 2021 or on the date immediately prior to the 2022 annual meeting of stockholders. F3 · derivative.expiration_date: 100% of the RSUs vest on the earlier of the one year anniversary of June 16, 2021 or on the date immediately prior to the 2022 annual meeting of stockholders. Read SEC document
June 15, 2021 Filed Jun 17, 2021 19:01 UTC	NanoString Technologies Inc NSTG · Entity 15988	Exercise / conversionCommon Stock · Derivative	5,520	$0.00	$0.00	Disclosure SEC source: 0001401708-21-000176 · wf-form4_162397086069886.xml · derivative · entry 2 KANIA DON R · CIK 0001254028 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,520 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one (1) share of Issuer's common stock. F2 · derivative.exercise_date: 100% of the RSUs vest on the earlier of the one year anniversary of June 16, 2020 or on the date immediately prior to the 2021 annual meeting of stockholders. F2 · derivative.expiration_date: 100% of the RSUs vest on the earlier of the one year anniversary of June 16, 2020 or on the date immediately prior to the 2021 annual meeting of stockholders. Read SEC document
June 15, 2021 Filed Jun 17, 2021 19:01 UTC	NanoString Technologies Inc NSTG · Entity 15988	Exercise / conversionCommon Stock	5,520	Not disclosed	Not disclosed	Disclosure SEC source: 0001401708-21-000176 · wf-form4_162397086069886.xml · nonDerivative · entry 1 KANIA DON R · CIK 0001254028 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,520 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one (1) share of Issuer's common stock. Read SEC document
April 22, 2021 Filed Apr 26, 2021 18:56 UTC	INTUITIVE SURGICAL INC ISRG · Entity 2878	GrantRestricted Stock Units · Derivative	185	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0001035267-21-000083 · edgardoc.xml · derivative · entry 4 KANIA DON R · CIK 0001254028 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 185 Underlying: Common Stock · 185 shares Expires not disclosed F2 · derivative.exercise_date: 100% of the RSUs shall vest on the earlier of the one year anniversary of the date of grant or the next Annual Meeting of Stockholders, subject to the Reporting Person's continued service. F2 · derivative.expiration_date: 100% of the RSUs shall vest on the earlier of the one year anniversary of the date of grant or the next Annual Meeting of Stockholders, subject to the Reporting Person's continued service. Read SEC document
April 22, 2021 Filed Apr 26, 2021 18:56 UTC	INTUITIVE SURGICAL INC ISRG · Entity 2878	Exercise / conversionRestricted Stock Units · Derivative	255	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0001035267-21-000083 · edgardoc.xml · derivative · entry 3 KANIA DON R · CIK 0001254028 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 255 shares Expires 2021-04-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 100% of the RSUs shall vest on the earlier of the one year anniversary of the date of grant or the next Annual Meeting of Stockholders, subject to the Reporting Person's continued service. Read SEC document
April 22, 2021 Filed Apr 26, 2021 18:56 UTC	INTUITIVE SURGICAL INC ISRG · Entity 2878	GrantNon-Qualified Stock Option (right to buy) · Derivative	557	$0.00 Strike: $859.66	$0.00	Disclosure SEC source: 0001035267-21-000083 · edgardoc.xml · derivative · entry 2 KANIA DON R · CIK 0001254028 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 557 Underlying: Common Stock · 557 shares Expires 2031-04-22 F1 · derivative.exercise_date: 100% of the shares subject to the option shall vest on the earlier of the one year anniversary of the date of grant or the next Annual Meeting of Stockholders, subject to the Reporting Person's continued service as a director to the issuer. Read SEC document
April 22, 2021 Filed Apr 26, 2021 18:56 UTC	INTUITIVE SURGICAL INC ISRG · Entity 2878	Exercise / conversionCommon Stock	255	$0.00	$0.00	Disclosure SEC source: 0001035267-21-000083 · edgardoc.xml · nonDerivative · entry 1 KANIA DON R · CIK 0001254028 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 744 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
June 16, 2020 Filed Jun 17, 2020 19:34 UTC	NanoString Technologies Inc NSTG · Entity 15988	GrantRestricted Stock Units · Derivative	5,520	$0.00	$0.00	Disclosure SEC source: 0001401708-20-000130 · wf-form4_159243682133337.xml · derivative · entry 1 KANIA DON R · CIK 0001254028 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,520 Underlying: Common Stock · 5,520 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one (1) share of Issuer's common stock. F2 · derivative.exercise_date: 100% of the RSUs vest on the earlier of the one year anniversary of June 16, 2020 or on the date immediately prior to the 2021 annual meeting of stockholders. F2 · derivative.expiration_date: 100% of the RSUs vest on the earlier of the one year anniversary of June 16, 2020 or on the date immediately prior to the 2021 annual meeting of stockholders. Read SEC document
April 23, 2020 Filed Apr 27, 2020 21:44 UTC	INTUITIVE SURGICAL INC ISRG · Entity 2878	GrantRestricted Stock Units · Derivative	255	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0001035267-20-000080 · edgardoc.xml · derivative · entry 4 KANIA DON R · CIK 0001254028 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 255 Underlying: Common Stock · 255 shares Expires 2021-04-23 F4 · derivative.exercise_date: 100% of the RSUs shall vest on the earlier of the one year anniversary of the date of grant or the next Annual Meeting of Stockholders, subject to the Reporting Person's continued service as a director to the issuer. Read SEC document
April 23, 2020 Filed Apr 27, 2020 21:44 UTC	INTUITIVE SURGICAL INC ISRG · Entity 2878	Exercise / conversionRestricted Stock Units · Derivative	262	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0001035267-20-000080 · edgardoc.xml · derivative · entry 3 KANIA DON R · CIK 0001254028 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 262 shares Expires 2020-04-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: 100% of the RSUs shall vest on the earlier of the one year anniversary of the date of grant or the next Annual Meeting of Stockholders, subject to the Reporting Person's continued service as a director to the issuer. Read SEC document
April 23, 2020 Filed Apr 27, 2020 21:44 UTC	INTUITIVE SURGICAL INC ISRG · Entity 2878	GrantNon-Qualified Stock Option (right to buy) · Derivative	766	$0.00 Strike: $513.22	$0.00	Disclosure SEC source: 0001035267-20-000080 · edgardoc.xml · derivative · entry 2 KANIA DON R · CIK 0001254028 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 766 Underlying: Common Stock · 766 shares Expires 2030-04-23 F3 · derivative.exercise_date: 100% of the shares subject to the option shall vest on the earlier of the one year anniversary of the date of grant or the next Annual Meeting of Stockholders, subject to the Reporting Person's continued service as a director to the issuer. Read SEC document
April 23, 2020 Filed Apr 27, 2020 21:44 UTC	INTUITIVE SURGICAL INC ISRG · Entity 2878	Exercise / conversionCommon Stock	262	$0.00	$0.00	Disclosure SEC source: 0001035267-20-000080 · edgardoc.xml · nonDerivative · entry 1 KANIA DON R · CIK 0001254028 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 489 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These shares were acquired from the vest and release of an RSU grant previously issued to the Filer. F2 · balance_after: Includes a total of 12 shares acquired in purchases by the reporting person's investment advisor for the reporting person's account on two different days in 2018 and one day in 2019, which the reporting person inadvertently failed to report on Form 4. Read SEC document
October 30, 2019 Filed Oct 31, 2019 18:21 UTC	NanoString Technologies Inc NSTG · Entity 15988	GrantStock Option (right to buy) · Derivative	16,963	$0.00 Strike: $11.79	$0.00	Disclosure SEC source: 0001401708-19-000208 · wf-form4_157256049379365.xml · derivative · entry 1 KANIA DON R · CIK 0001254028 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,983 Underlying: Common Stock · 16,963 shares Expires 2029-10-30 F1 · derivative.exercise_date: 1/3 of the shares subject to the Option vest on each of the following three yearly anniversaries of October 30, 2019. Read SEC document
October 30, 2019 Filed Jun 3, 2022 16:24 UTC Amendment	NanoString Technologies Inc NSTG · Entity 15988	GrantStock Option (right to buy) · Derivative	16,963	$0.00 Strike: $23.00	$0.00	Disclosure SEC source: 0001401708-22-000104 · wf-form4a_165428782391995.xml · derivative · entry 1 KANIA DON R · CIK 0001254028 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,983 Underlying: Common Stock · 16,963 shares Expires 2029-10-30 F1 · derivative.exercise_price: On October 31, 2019, the Reporting Person filed a Form 4 which inadvertently misstated the conversion or exercise price of a Stock Option in Table II. The conversion or exercise price reported in Column 2 of this Form 4 reflects the corrected conversion or exercise price as of the date of such transaction. F2 · derivative.exercise_date: 1/3 of the shares subject to the Option vest on each of the following three yearly anniversaries of October 30, 2019. Read SEC document
July 31, 2019 Filed Aug 1, 2019 20:46 UTC	INTUITIVE SURGICAL INC ISRG · Entity 2878	Exercise / conversionRestricted Stock Units · Derivative	215	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0001567619-19-015615 · doc1.xml · derivative · entry 2 KANIA DON R · CIK 0001254028 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 215 shares Expires 2019-07-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Restricted Stock Units (RSUs) are granted pursuant to the 2010 Incentive Award Plan. The RSUs fully vest on the first anniversary of the date of grant. Read SEC document
July 31, 2019 Filed Aug 1, 2019 20:46 UTC	INTUITIVE SURGICAL INC ISRG · Entity 2878	Exercise / conversionCommon Stock	215	$0.00	$0.00	Disclosure SEC source: 0001567619-19-015615 · doc1.xml · nonDerivative · entry 1 KANIA DON R · CIK 0001254028 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 215 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
April 25, 2019 Filed Apr 26, 2019 00:15 UTC	INTUITIVE SURGICAL INC ISRG · Entity 2878	GrantRestricted Stock Units · Derivative	262	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0001035267-19-000061 · edgardoc.xml · derivative · entry 2 KANIA DON R · CIK 0001254028 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 262 Underlying: Common Stock · 262 shares Expires 2020-04-26 F2 · derivative.exercise_date: Options will vest 100% on the earlier of the first anniversary of the date of grant or the date of the next annual stockholders meeting. Read SEC document
April 25, 2019 Filed Apr 26, 2019 00:15 UTC	INTUITIVE SURGICAL INC ISRG · Entity 2878	GrantNon-Qualified Stock Option (right to buy) · Derivative	786	$0.00 Strike: $517.78	$0.00	Disclosure SEC source: 0001035267-19-000061 · edgardoc.xml · derivative · entry 1 KANIA DON R · CIK 0001254028 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 786 Underlying: Common Stock · 786 shares Expires 2029-04-25 F1 · derivative.exercise_date: Non-statutory stock option granted pursuant to the Non-Employee Directors' Stock Option Plan. Option shall vest 100% one year after the date of grant or at the next Shareholders Meeting, whichever should take place first, provided that vesting will cease on termination of the Directors service to the Company. Read SEC document
July 31, 2018 Filed Aug 2, 2018 01:17 UTC	INTUITIVE SURGICAL INC ISRG · Entity 2878	GrantRestricted Stock Units · Derivative	215	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0001035267-18-000105 · edgardoc.xml · derivative · entry 2 KANIA DON R · CIK 0001254028 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 215 Underlying: Common Stock · 215 shares Expires 2019-07-31 F2 · derivative.exercise_date: RSUs will vest 100% on the first anniversary of the date of grant. Read SEC document
July 31, 2018 Filed Aug 2, 2018 01:17 UTC	INTUITIVE SURGICAL INC ISRG · Entity 2878	GrantNon-Qualified Stock Option (right to buy) · Derivative	647	$0.00 Strike: $508.19	$0.00	Disclosure SEC source: 0001035267-18-000105 · edgardoc.xml · derivative · entry 1 KANIA DON R · CIK 0001254028 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 647 Underlying: Common Stock · 647 shares Expires 2028-07-31 F1 · derivative.exercise_date: Options will vest 100% on the first anniversary of the date of grant. Read SEC document
September 19, 2016 Filed Sep 21, 2016 13:42 UTC	FEI CO FEIC · Entity 182178	Disposition to issuerRSUs · Derivative	34,284	Not disclosed Strike: $0.00	Not disclosed	Disclosure SEC source: 0000899243-16-029573 · doc4.xml · derivative · entry 13 KANIA DON R · CIK 0001254028 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 34,284 shares Expires not disclosed F8 · derivative.exercise_price: Each of the restricted share units ("RSUs") represents the right to receive, following vesting, one share of the Issuer's common stock. These RSUs do not expire, unless forfeited under the terms of the RSUs. F15 · price: The RSUs were scheduled to vest in four equal annual installments beginning on May 17, 2017. At or immediately prior to the effective time of the Merger, the outstanding RSUs were assumed by Thermo Fisher and converted into an award representing a right to receive a cash amount equal to (x) $107.50 multiplied by (y) the total number of outstanding shares of the Issuer's common stock that would have been delivered to Mr. Kania on each future vesting date of such RSUs (or on each future delivery date of such RSUs, if such delivery date is later than the related vesting date), subject to the vesting and delivery terms of the Issuer's 1995 Stock Incentive Plan and the award agreement evidencing such RSUs, in each case as in effect immediately prior to the effective time of the Merger. F15 · derivative.exercise_date: The RSUs were scheduled to vest in four equal annual installments beginning on May 17, 2017. At or immediately prior to the effective time of the Merger, the outstanding RSUs were assumed by Thermo Fisher and converted into an award representing a right to receive a cash amount equal to (x) $107.50 multiplied by (y) the total number of outstanding shares of the Issuer's common stock that would have been delivered to Mr. Kania on each future vesting date of such RSUs (or on each future delivery date of such RSUs, if such delivery date is later than the related vesting date), subject to the vesting and delivery terms of the Issuer's 1995 Stock Incentive Plan and the award agreement evidencing such RSUs, in each case as in effect immediately prior to the effective time of the Merger. F8 · derivative.expiration_date: Each of the restricted share units ("RSUs") represents the right to receive, following vesting, one share of the Issuer's common stock. These RSUs do not expire, unless forfeited under the terms of the RSUs. Read SEC document
September 19, 2016 Filed Sep 21, 2016 13:42 UTC	FEI CO FEIC · Entity 182178	Disposition to issuerPerformance-based RSUs · Derivative	19,109	Not disclosed Strike: $0.00	Not disclosed	Disclosure SEC source: 0000899243-16-029573 · doc4.xml · derivative · entry 12 KANIA DON R · CIK 0001254028 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 19,109 shares Expires not disclosed F13 · derivative.exercise_price: These RSUs are performance-based RSUs, for which the number of RSUs that would vest was to be determined by the Issuer achieving targeted average annual revenue growth during the period from January 1, 2016 through December 31, 2018. In addition, vesting was subject to minimum thresholds for average operating income and average annual revenue growth. A portion of the RSUs were scheduled to vest if the Issuer achieved the thresholds and vesting would increase with performance up to a cap of 19,109 RSUs, which represented 200% of the RSUs that vest upon achievement of the performance metrics at target levels. Performance would be assessed and vesting determined after the Issuer finalized financial results for 2018, which was expected to be on or about February 6, 2019. RSUs that did not vest in accordance with the foregoing would be forfeited. F14 · price: At or immediately prior to the effective time of the Merger, these performance-based RSUs were assumed by Thermo Fisher and converted into an award representing a right to receive a cash amount equal to (x) $107.50 multiplied by (y) the total number of outstanding shares of the Issuer's common stock that would have been delivered to Mr. Kania on each future vesting date of such RSUs (or on each future delivery date of such RSUs, if such delivery date is later than the related vesting date), subject to the vesting and delivery terms of the Issuer's 1995 Stock Incentive Plan and the award agreement evidencing such RSUs, in each case as in effect immediately prior to the effective time of the Merger, except that the performance metrics were deemed to have been achieved at target as of the effective time of the Merger. F13 · derivative.exercise_date: These RSUs are performance-based RSUs, for which the number of RSUs that would vest was to be determined by the Issuer achieving targeted average annual revenue growth during the period from January 1, 2016 through December 31, 2018. In addition, vesting was subject to minimum thresholds for average operating income and average annual revenue growth. A portion of the RSUs were scheduled to vest if the Issuer achieved the thresholds and vesting would increase with performance up to a cap of 19,109 RSUs, which represented 200% of the RSUs that vest upon achievement of the performance metrics at target levels. Performance would be assessed and vesting determined after the Issuer finalized financial results for 2018, which was expected to be on or about February 6, 2019. RSUs that did not vest in accordance with the foregoing would be forfeited. F8 · derivative.expiration_date: Each of the restricted share units ("RSUs") represents the right to receive, following vesting, one share of the Issuer's common stock. These RSUs do not expire, unless forfeited under the terms of the RSUs. Read SEC document
September 19, 2016 Filed Sep 21, 2016 13:42 UTC	FEI CO FEIC · Entity 182178	Disposition to issuerRSUs · Derivative	12,405	Not disclosed Strike: $0.00	Not disclosed	Disclosure SEC source: 0000899243-16-029573 · doc4.xml · derivative · entry 11 KANIA DON R · CIK 0001254028 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 12,405 shares Expires not disclosed F8 · derivative.exercise_price: Each of the restricted share units ("RSUs") represents the right to receive, following vesting, one share of the Issuer's common stock. These RSUs do not expire, unless forfeited under the terms of the RSUs. F12 · price: The RSUs were scheduled to vest in four equal annual installments beginning on May 23, 2016. At or immediately prior to the effective time of the Merger, the outstanding RSUs were assumed by Thermo Fisher and converted into an award representing a right to receive a cash amount equal to (x) $107.50 multiplied by (y) the total number of outstanding shares of the Issuer's common stock that would have been delivered to Mr. Kania on each future vesting date of such RSUs (or on each future delivery date of such RSUs, if such delivery date is later than the related vesting date), subject to the vesting and delivery terms of the Issuer's 1995 Stock Incentive Plan and the award agreement evidencing such RSUs, in each case as in effect immediately prior to the effective time of the Merger. F12 · derivative.exercise_date: The RSUs were scheduled to vest in four equal annual installments beginning on May 23, 2016. At or immediately prior to the effective time of the Merger, the outstanding RSUs were assumed by Thermo Fisher and converted into an award representing a right to receive a cash amount equal to (x) $107.50 multiplied by (y) the total number of outstanding shares of the Issuer's common stock that would have been delivered to Mr. Kania on each future vesting date of such RSUs (or on each future delivery date of such RSUs, if such delivery date is later than the related vesting date), subject to the vesting and delivery terms of the Issuer's 1995 Stock Incentive Plan and the award agreement evidencing such RSUs, in each case as in effect immediately prior to the effective time of the Merger. F8 · derivative.expiration_date: Each of the restricted share units ("RSUs") represents the right to receive, following vesting, one share of the Issuer's common stock. These RSUs do not expire, unless forfeited under the terms of the RSUs. Read SEC document
September 19, 2016 Filed Sep 21, 2016 13:42 UTC	FEI CO FEIC · Entity 182178	Disposition to issuerRSUs · Derivative	7,692	Not disclosed Strike: $0.00	Not disclosed	Disclosure SEC source: 0000899243-16-029573 · doc4.xml · derivative · entry 10 KANIA DON R · CIK 0001254028 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,692 shares Expires not disclosed F8 · derivative.exercise_price: Each of the restricted share units ("RSUs") represents the right to receive, following vesting, one share of the Issuer's common stock. These RSUs do not expire, unless forfeited under the terms of the RSUs. F11 · price: The RSUs were scheduled to vest in four equal annual installments beginning on May 9, 2015. At or immediately prior to the effective time of the Merger, the outstanding RSUs were assumed by Thermo Fisher and converted into an award representing a right to receive a cash amount equal to (x) $107.50 multiplied by (y) the total number of outstanding shares of the Issuer's common stock that would have been delivered to Mr. Kania on each future vesting date of such RSUs (or on each future delivery date of such RSUs, if such delivery date is later than the related vesting date), subject to the vesting and delivery terms of the Issuer's 1995 Stock Incentive Plan and the award agreement evidencing such RSUs, in each case as in effect immediately prior to the effective time of the Merger. F11 · derivative.exercise_date: The RSUs were scheduled to vest in four equal annual installments beginning on May 9, 2015. At or immediately prior to the effective time of the Merger, the outstanding RSUs were assumed by Thermo Fisher and converted into an award representing a right to receive a cash amount equal to (x) $107.50 multiplied by (y) the total number of outstanding shares of the Issuer's common stock that would have been delivered to Mr. Kania on each future vesting date of such RSUs (or on each future delivery date of such RSUs, if such delivery date is later than the related vesting date), subject to the vesting and delivery terms of the Issuer's 1995 Stock Incentive Plan and the award agreement evidencing such RSUs, in each case as in effect immediately prior to the effective time of the Merger. F8 · derivative.expiration_date: Each of the restricted share units ("RSUs") represents the right to receive, following vesting, one share of the Issuer's common stock. These RSUs do not expire, unless forfeited under the terms of the RSUs. Read SEC document
September 19, 2016 Filed Sep 21, 2016 13:42 UTC	FEI CO FEIC · Entity 182178	Disposition to issuerRSUs · Derivative	7,952	Not disclosed Strike: $0.00	Not disclosed	Disclosure SEC source: 0000899243-16-029573 · doc4.xml · derivative · entry 9 KANIA DON R · CIK 0001254028 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,952 shares Expires not disclosed F8 · derivative.exercise_price: Each of the restricted share units ("RSUs") represents the right to receive, following vesting, one share of the Issuer's common stock. These RSUs do not expire, unless forfeited under the terms of the RSUs. F10 · price: The RSUs were scheduled to vest in four equal annual installments beginning on October 31, 2014. At or immediately prior to the effective time of the Merger, the outstanding RSUs were assumed by Thermo Fisher and converted into an award representing a right to receive a cash amount equal to (x) $107.50 multiplied by (y) the total number of outstanding shares of the Issuer's common stock that would have been delivered to Mr. Kania on each future vesting date of such RSUs (or on each future delivery date of such RSUs, if such delivery date is later than the related vesting date), subject to the vesting and delivery terms of the Issuer's 1995 Stock Incentive Plan and the award agreement evidencing such RSUs, in each case as in effect immediately prior to the effective time of the Merger. F10 · derivative.exercise_date: The RSUs were scheduled to vest in four equal annual installments beginning on October 31, 2014. At or immediately prior to the effective time of the Merger, the outstanding RSUs were assumed by Thermo Fisher and converted into an award representing a right to receive a cash amount equal to (x) $107.50 multiplied by (y) the total number of outstanding shares of the Issuer's common stock that would have been delivered to Mr. Kania on each future vesting date of such RSUs (or on each future delivery date of such RSUs, if such delivery date is later than the related vesting date), subject to the vesting and delivery terms of the Issuer's 1995 Stock Incentive Plan and the award agreement evidencing such RSUs, in each case as in effect immediately prior to the effective time of the Merger. F8 · derivative.expiration_date: Each of the restricted share units ("RSUs") represents the right to receive, following vesting, one share of the Issuer's common stock. These RSUs do not expire, unless forfeited under the terms of the RSUs. Read SEC document
September 19, 2016 Filed Sep 21, 2016 13:42 UTC	FEI CO FEIC · Entity 182178	Disposition to issuerRSUs · Derivative	5,844	Not disclosed Strike: $0.00	Not disclosed	Disclosure SEC source: 0000899243-16-029573 · doc4.xml · derivative · entry 8 KANIA DON R · CIK 0001254028 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,844 shares Expires not disclosed F8 · derivative.exercise_price: Each of the restricted share units ("RSUs") represents the right to receive, following vesting, one share of the Issuer's common stock. These RSUs do not expire, unless forfeited under the terms of the RSUs. F9 · price: The RSUs were scheduled to vest in four equal annual installments beginning on November 1, 2013. At or immediately prior to the effective time of the Merger, the outstanding RSUs were assumed by Thermo Fisher and converted into an award representing a right to receive a cash amount equal to (x) $107.50 multiplied by (y) the total number of outstanding shares of the Issuer's common stock that would have been delivered to Mr. Kania on each future vesting date of such RSUs (or on each future delivery date of such RSUs, if such delivery date is later than the related vesting date), subject to the vesting and delivery terms of the Issuer's 1995 Stock Incentive Plan and the award agreement evidencing such RSUs, in each case as in effect immediately prior to the effective time of the Merger. F9 · derivative.exercise_date: The RSUs were scheduled to vest in four equal annual installments beginning on November 1, 2013. At or immediately prior to the effective time of the Merger, the outstanding RSUs were assumed by Thermo Fisher and converted into an award representing a right to receive a cash amount equal to (x) $107.50 multiplied by (y) the total number of outstanding shares of the Issuer's common stock that would have been delivered to Mr. Kania on each future vesting date of such RSUs (or on each future delivery date of such RSUs, if such delivery date is later than the related vesting date), subject to the vesting and delivery terms of the Issuer's 1995 Stock Incentive Plan and the award agreement evidencing such RSUs, in each case as in effect immediately prior to the effective time of the Merger. F8 · derivative.expiration_date: Each of the restricted share units ("RSUs") represents the right to receive, following vesting, one share of the Issuer's common stock. These RSUs do not expire, unless forfeited under the terms of the RSUs. Read SEC document
September 19, 2016 Filed Sep 21, 2016 13:42 UTC	FEI CO FEIC · Entity 182178	Disposition to issuerStock Options · Derivative	82,697	Not disclosed Strike: $81.15	Not disclosed	Disclosure SEC source: 0000899243-16-029573 · doc4.xml · derivative · entry 7 KANIA DON R · CIK 0001254028 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 82,697 shares Expires 2022-05-22 F7 · price: The option was scheduled to vest in four equal annual installments beginning on May 22, 2016. At or immediately prior to the effective time of the Merger, the unexercised portion of the option was assumed by Thermo Fisher and converted into an award representing a right to receive a cash amount equal to (x) the difference between $107.50 and the per share exercise price of the option, multiplied by (y) the number of shares subject to such portion of the option, subject to the vesting terms of the Issuer's 1995 Stock Incentive Plan and the award agreement evidencing such option, in each case as in effect immediately prior to the effective time of the Merger. F7 · derivative.exercise_date: The option was scheduled to vest in four equal annual installments beginning on May 22, 2016. At or immediately prior to the effective time of the Merger, the unexercised portion of the option was assumed by Thermo Fisher and converted into an award representing a right to receive a cash amount equal to (x) the difference between $107.50 and the per share exercise price of the option, multiplied by (y) the number of shares subject to such portion of the option, subject to the vesting terms of the Issuer's 1995 Stock Incentive Plan and the award agreement evidencing such option, in each case as in effect immediately prior to the effective time of the Merger. Read SEC document
September 19, 2016 Filed Sep 21, 2016 13:42 UTC	FEI CO FEIC · Entity 182178	Disposition to issuerStock Options · Derivative	64,612	Not disclosed Strike: $81.88	Not disclosed	Disclosure SEC source: 0000899243-16-029573 · doc4.xml · derivative · entry 6 KANIA DON R · CIK 0001254028 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 64,612 shares Expires 2021-05-19 F6 · price: The option was scheduled to vest in four equal annual installments beginning on May 19, 2015. At or immediately prior to the effective time of the Merger, the unexercised portion of the option was assumed by Thermo Fisher and converted into an award representing a right to receive a cash amount equal to (x) the difference between $107.50 and the per share exercise price of the option, multiplied by (y) the number of shares subject to such portion of the option, subject to the vesting terms of the Issuer's 1995 Stock Incentive Plan and the award agreement evidencing such option, in each case as in effect immediately prior to the effective time of the Merger. F6 · derivative.exercise_date: The option was scheduled to vest in four equal annual installments beginning on May 19, 2015. At or immediately prior to the effective time of the Merger, the unexercised portion of the option was assumed by Thermo Fisher and converted into an award representing a right to receive a cash amount equal to (x) the difference between $107.50 and the per share exercise price of the option, multiplied by (y) the number of shares subject to such portion of the option, subject to the vesting terms of the Issuer's 1995 Stock Incentive Plan and the award agreement evidencing such option, in each case as in effect immediately prior to the effective time of the Merger. Read SEC document
September 19, 2016 Filed Sep 21, 2016 13:42 UTC	FEI CO FEIC · Entity 182178	Disposition to issuerStock Options · Derivative	41,356	Not disclosed Strike: $89.08	Not disclosed	Disclosure SEC source: 0000899243-16-029573 · doc4.xml · derivative · entry 5 KANIA DON R · CIK 0001254028 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 41,356 shares Expires 2020-10-31 F5 · price: The option was scheduled to vest in four equal annual installments beginning on October 31, 2014. At or immediately prior to the effective time of the Merger, the unexercised portion of the option was assumed by Thermo Fisher and converted into an award representing a right to receive a cash amount equal to (x) the difference between $107.50 and the per share exercise price of the option, multiplied by (y) the number of shares subject to such portion of the option, subject to the vesting terms of the Issuer's 1995 Stock Incentive Plan and the award agreement evidencing such option, in each case as in effect immediately prior to the effective time of the Merger. F5 · derivative.exercise_date: The option was scheduled to vest in four equal annual installments beginning on October 31, 2014. At or immediately prior to the effective time of the Merger, the unexercised portion of the option was assumed by Thermo Fisher and converted into an award representing a right to receive a cash amount equal to (x) the difference between $107.50 and the per share exercise price of the option, multiplied by (y) the number of shares subject to such portion of the option, subject to the vesting terms of the Issuer's 1995 Stock Incentive Plan and the award agreement evidencing such option, in each case as in effect immediately prior to the effective time of the Merger. Read SEC document
September 19, 2016 Filed Sep 21, 2016 13:42 UTC	FEI CO FEIC · Entity 182178	Disposition to issuerStock Options · Derivative	60,776	Not disclosed Strike: $55.16	Not disclosed	Disclosure SEC source: 0000899243-16-029573 · doc4.xml · derivative · entry 4 KANIA DON R · CIK 0001254028 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 60,776 shares Expires 2019-11-01 F4 · price: The option was scheduled to vest in four equal annual installments beginning on November 1, 2013. At or immediately prior to the effective time of the Merger, the unexercised portion of the option was assumed by Thermo Fisher and converted into an award representing a right to receive a cash amount equal to (x) the difference between $107.50 and the per share exercise price of the option, multiplied by (y) the number of shares subject to such portion of the option, subject to the vesting terms of the Issuer's 1995 Stock Incentive Plan and the award agreement evidencing such option, in each case as in effect immediately prior to the effective time of the Merger. F4 · derivative.exercise_date: The option was scheduled to vest in four equal annual installments beginning on November 1, 2013. At or immediately prior to the effective time of the Merger, the unexercised portion of the option was assumed by Thermo Fisher and converted into an award representing a right to receive a cash amount equal to (x) the difference between $107.50 and the per share exercise price of the option, multiplied by (y) the number of shares subject to such portion of the option, subject to the vesting terms of the Issuer's 1995 Stock Incentive Plan and the award agreement evidencing such option, in each case as in effect immediately prior to the effective time of the Merger. Read SEC document
September 19, 2016 Filed Sep 21, 2016 13:42 UTC	FEI CO FEIC · Entity 182178	Disposition to issuerStock Options · Derivative	37,412	Not disclosed Strike: $39.76	Not disclosed	Disclosure SEC source: 0000899243-16-029573 · doc4.xml · derivative · entry 3 KANIA DON R · CIK 0001254028 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 37,412 shares Expires 2018-10-31 F3 · price: The option, which became fully vested on October 31, 2015, originally covered 74,824 shares but was exercised as to 37,412 shares prior to the Merger. At or immediately prior to the effective time of the Merger, the unexercised portion of the option was cancelled in exchange for a cash payment equal to (x) the difference between $107.50 and the per share exercise price of the option, multiplied by (y) the number of shares subject to such portion of the option. F3 · derivative.exercise_date: The option, which became fully vested on October 31, 2015, originally covered 74,824 shares but was exercised as to 37,412 shares prior to the Merger. At or immediately prior to the effective time of the Merger, the unexercised portion of the option was cancelled in exchange for a cash payment equal to (x) the difference between $107.50 and the per share exercise price of the option, multiplied by (y) the number of shares subject to such portion of the option. Read SEC document
September 19, 2016 Filed Sep 21, 2016 13:42 UTC	FEI CO FEIC · Entity 182178	Disposition to issuerStock Options · Derivative	26,000	Not disclosed Strike: $23.98	Not disclosed	Disclosure SEC source: 0000899243-16-029573 · doc4.xml · derivative · entry 2 KANIA DON R · CIK 0001254028 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 26,000 shares Expires 2017-11-04 F2 · price: The option, which became fully vested on November 4, 2014, originally covered 72,000 shares but was exercised as to 46,000 shares prior to the Merger. At or immediately prior to the effective time of the Merger, the unexercised portion of the option was cancelled in exchange for a cash payment equal to (x) the difference between $107.50 and the per share exercise price of the option, multiplied by (y) the number of shares subject to such portion of the option. F2 · derivative.exercise_date: The option, which became fully vested on November 4, 2014, originally covered 72,000 shares but was exercised as to 46,000 shares prior to the Merger. At or immediately prior to the effective time of the Merger, the unexercised portion of the option was cancelled in exchange for a cash payment equal to (x) the difference between $107.50 and the per share exercise price of the option, multiplied by (y) the number of shares subject to such portion of the option. Read SEC document
September 19, 2016 Filed Sep 21, 2016 13:42 UTC	FEI CO FEIC · Entity 182178	OtherCommon Stock	48,486	Not disclosed	Not disclosed	Disclosure SEC source: 0000899243-16-029573 · doc4.xml · nonDerivative · entry 1 KANIA DON R · CIK 0001254028 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: Disposed of at the effective time of the merger of Polpis Merger Sub Co. ("Merger Sub"), a wholly owned subsidiary of Thermo Fisher Scientific Inc. ("Thermo Fisher"), with and into the Issuer (the "Merger"), pursuant to that certain Agreement and Plan of Merger dated May 26, 2016, between the Issuer, Thermo Fisher and Merger Sub (the "Merger Agreement"), in exchange for a cash payment of $107.50 per share. Read SEC document
September 09, 2016 Filed Sep 12, 2016 07:40 UTC	AMERICAN SCIENCE & ENGINEERING, INC. ASEI · Entity 182433	Disposition to issuerStock Option · Derivative	7,000	Not disclosed Strike: $74.79	Not disclosed	Disclosure SEC source: 0001104659-16-144121 · a4.xml · derivative · entry 3 KANIA DON R · CIK 0001254028 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,000 shares Expires 2020-09-08 F2 · price: This option was cancelled for no consideration pursuant to the terms of the Merger Agreement. Read SEC document
September 09, 2016 Filed Sep 12, 2016 07:40 UTC	AMERICAN SCIENCE & ENGINEERING, INC. ASEI · Entity 182433	Disposition to issuerStock Option · Derivative	4,181	Not disclosed Strike: $75.82	Not disclosed	Disclosure SEC source: 0001104659-16-144121 · a4.xml · derivative · entry 2 KANIA DON R · CIK 0001254028 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,181 shares Expires 2020-05-02 F2 · price: This option was cancelled for no consideration pursuant to the terms of the Merger Agreement. Read SEC document
September 09, 2016 Filed Sep 12, 2016 07:40 UTC	AMERICAN SCIENCE & ENGINEERING, INC. ASEI · Entity 182433	Disposition to issuerCommon Stock	10,847	$37.00	$401,339.00	Disclosure SEC source: 0001104659-16-144121 · a4.xml · nonDerivative · entry 1 KANIA DON R · CIK 0001254028 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: On September 9, 2016, pursuant to the Agreement and Plan of Merger among the issuer, OSI Systems, Inc. ("Buyer") and Apple Merger Sub, Inc., a wholly owned subsidiary of Buyer ("Merger Sub"), dated June 20, 2016 (the "Merger Agreement"), Merger Sub merged with and into the issuer (the "Merger"), with the issuer surviving the Merger as a wholly owned subsidiary of Buyer. Pursuant to the Merger Agreement, at the effective time of the Merger, the shares automatically converted into the right to receive $37.00 per share in cash. Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.